As a result, the company is updating its labeling instructions to show how physicians can reduce the number of patient visits to their office for routine device follow-up without compromising the quality of care these patients receive. TRUST is the first and largest study to test the ability of remote monitoring in reducing in-office follow-ups.
 

«« FDA Warns About Stolen Levemir Long-Acting Insulin


Statin Loading for PCI Established as Standard of Care »»


Latest Articles

As a result, the company is updating its labeling instructions to show how physicians can reduce the number of patient visits to their office for routine...